Comparison of the Analgesic Efficacy of Erector Spinae Plane Block in Breast-Conserving Surgery Versus Serratus Anterior Block Combined With Additional Pecto-Intercostal II Block

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-75
SponsorKayseri City Hospital

About this trial

This prospective randomized study will compare the effects of Erector Spinae Plane Block (ESPB) and Serratus Anterior Plane Block combined with Pectoral Nerve Block Type II (SAPB + PECS II) on intraoperative analgesia and postoperative opioid consumption in patients undergoing breast cancer surgery. Seventy patients (ASA I-III, aged 18-75 years) will be randomized into two groups using the sealed envelope method. Ultrasound-guided blocks will be performed preoperatively by the same anesthesiologist, with Group 1 receiving ESPB and Group 2 receiving a combined SAPB + PECS II technique performed through a single skin puncture (single needle entry site) with sequential injections into the two target fascial planes. All patients will undergo surgery under general anesthesia and receive postoperative analgesia via morphine patient-controlled analgesia. Pain scores and total opioid consumption will be statistically analyzed, with p \< 0.05 considered significant.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age between 18 and 75 years

ASA physical status I-III

No history of bleeding or coagulation disorders

Absence of neuropathy

Disqualifiers

systemic or regional infection

known allergy to local anesthetics

Unwillingness to participate in the study

Trial design

Design model

Parallel

Treatments tested in this trial

  • SAPB + PECS II Technique

    Procedure/Surgery

    Investigators will perform both blocks with a single injection.

  • Erector Spinae Plane Block

    Procedure/Surgery

    Investigators will perform the block before the patient receives general anesthesia and investigators will check it with the pinprick test.

Treatment groups

70 Participants
are divided into 2 treatment groups
Group A: Erector Spinae Plane BlockActive comparator 1 intervention
Group B: SAPB + PECS II TechniqueActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

the Numerical Rating Scale

The Numerical Rating Scale is a subjective pain assessment tool in which patients rate their pain intensity on a scale from 0 to 10, where 0 indicates no pain (the best/most favorable score) and 10 represents the worst pain imaginable (the worst/least favorable score)

Time frame
24 hours or until the patient is discharged

Secondary outcomes

1

Nausea and Vomiting Scale

Nausea and vomiting were assessed using the Nausea and Vomiting Scale, scored between 0 and 4 (0 = no symptoms \[best/most favorable score\], 1 = mild nausea, 2 = moderate nausea, 3 = frequent vomiting, approximately four episodes, 4 = continuous vomiting \[worst/least favorable score\]).

Time frame
24 hours or until the patient is discharged
2

Apfel Risk Score

The Apfel Risk Score is a simplified risk assessment tool used to predict postoperative nausea and vomiting (PONV). It consists of four independent risk factors: female gender, non-smoking status, history of PONV or motion sickness, and planned postoperative opioid use. The risk of PONV increases proportionally with the number of risk factors present.

Time frame
24 hours or until the patient is discharged

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.